Jul 28
|
Health Care Roundup: Market Talk
|
Jul 28
|
Sector Update: Health Care Stocks Softer Monday Afternoon
|
Jul 28
|
Astrazeneca, Other US-Listed Pharma Companies Seen Insulated From New EU Tariff Deal, Barclays Says
|
Jul 25
|
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Gain 1.6% for Week
|
Jul 24
|
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Thursday Trading
|
Jul 22
|
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
|
Jul 18
|
European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
|
Jul 17
|
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading
|
Jul 16
|
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
|
Jul 15
|
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading
|
Jun 26
|
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading
|
Jun 12
|
High Growth Tech Stocks In Europe To Watch June 2025
|
Jun 2
|
GRFS vs. STVN: Which Stock Is the Better Value Option?
|
May 30
|
US court proceeds with Grifols defamation case against Gotham City, but narrows scope
|
May 28
|
ADMA Biologics vs. Grifols: Which Plasma Therapy Stock Is the Better Buy?
|
Jan 2
|
Exploring Three High Growth Tech Stocks For Future Potential
|
Aug 29
|
Brookfield Courts Sovereign Funds to Join Grifols Takeover Bid
|
Aug 26
|
This Reviled Pharmaceutical Firm Holds Promise of a Healthier Future
|
Jul 29
|
Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patients
|
Jun 18
|
Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group
|